Seeing Is Believing
Currently, out of the existing stock ratings of Robert Jones - 40 which are a Hold (41.67%), 11 which are a Sell (11.46%), 45 which are a Buy (46.88%)
Analyst Robert Jones works at GOLDMAN SACHS and is covering the Healthcare sector with 183 price targets and ratings displayed on 23 stocks. Previously, Robert Jones worked at GOLDMAN SACHS.
Robert Jones's average stock forecast success ratio is 75.83% with an average time for price targets to be met of 306.04 days.
Most recent stock forecast was given on ALGN, Align Technology at 27-Jul-2023.
Analyst best performing recommendations are on ANTM (ANTHEM).
The best stock recommendation documented was for XRAY (DENTSPLY SIRONA) at 4/7/2020. The price target of $40 was fulfilled within 2 days with a profit of $2.81 (7.56%) receiving and performance score of 37.78.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
187
1 months 26 days ago
15/15 (100%)
$29.05 (28.18%)
699
Hold
2 months ago
6/6 (100%)
$13.21 (16.25%)
529
Buy
220
$45.04 (25.74%)
213
2 months ago
11/17 (64.71%)
$32.27 (25.98%)
326
Buy
215
$40.04 (22.89%)
2 months ago
6/7 (85.71%)
$15.45 (13.67%)
220
Buy
225
$50.04 (28.60%)
2 months 2 days ago
11/12 (91.67%)
$21.83 (21.51%)
560
Which stock is Robert Jones is most bullish on?
What Year was the first public recommendation made by Robert Jones?